Recent advances in enterotoxin vaccine adjuvants

Area of Science:

• Immunology
• Vaccinology
• Microbiology

Background:

• Enterotoxin adjuvants, derived from bacterial toxins like cholera toxin and E. coli heat-labile toxin, are potent immune enhancers.
• Despite their potential, they are not widely used in licensed vaccines beyond cholera.

Purpose of the Study:

• To review recent advancements in enterotoxin adjuvants.
• To highlight their safety, efficacy, and mechanistic insights in vaccine development.

Main Methods:

• Review of clinical trial data on safety and efficacy.
• Analysis of preclinical vaccine studies.
• Examination of mechanistic studies on immune responses.

Main Results:

• Enterotoxin adjuvants promote robust cellular and humoral immunity.
• Demonstrated safety and efficacy in various clinical and preclinical studies.
• Versatile administration routes including mucosal delivery.

Conclusions:

• Enterotoxin adjuvants show significant promise for diverse vaccine applications.
• Further research supports their inclusion in vaccines against infectious diseases and substance abuse.